drugset / Trial / NCT00720265
A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
To prove non-inferiority of MR4 to Prograf by evaluating the efficacy and safety of Prograf and MR4 in new kidney transplant recipients
Timeline
- Start
- 2006-02
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | — | Oral |
Indications
No indication recorded.